Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30
$0.80−0.01 (-0.86%)
Close on Nov 16, 2026Market cap $103.34MP/E –Yield –
Organogenesis operating margin
Operating margin is operating income as a percentage of revenue.
Organogenesis's operating margin for the twelve months ending Jun 30, 2026 was -7.8%. For fiscal 2025 it was 7.9%, against -0.3% the year before. The highest annual figure on record is 15.5% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.9% | +8.2 |
| FY2024 | Dec 31, 2024 | -0.3% | −3.2 |
| FY2023 | Dec 31, 2023 | 2.9% | −2.1 |
| FY2022 | Dec 31, 2022 | 4.9% | −10.5 |
| FY2021 | Dec 31, 2021 | 15.5% | +7.6 |
| FY2020 | Dec 31, 2020 | 7.9% | +19.3 |
| FY2019 | Dec 31, 2019 | -11.4% | +15.2 |
| FY2018 | Dec 31, 2018 | -26.7% | −23.9 |
| FY2017 | Dec 31, 2017 | -2.8% | +3.6 |
| FY2016 | Dec 31, 2016 | -6.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -116.5% | −104.1 |
| Q1 FY2026 | Mar 31, 2026 | -185.1% | −154.2 |
| Q4 FY2025 | Dec 31, 2025 | 28.1% | +20.0 |
| Q3 FY2025 | Sep 30, 2025 | 13.7% | +8.3 |
| Q2 FY2025 | Jun 30, 2025 | -12.5% | −1.8 |
| Q1 FY2025 | Mar 31, 2025 | -30.9% | −27.3 |
| Q4 FY2024 | Dec 31, 2024 | 8.1% | +9.3 |
| Q3 FY2024 | Sep 30, 2024 | 5.4% | −2.0 |
| Q2 FY2024 | Jun 30, 2024 | -10.7% | −19.0 |
| Q1 FY2024 | Mar 31, 2024 | -3.5% | +0.2 |
| Q4 FY2023 | Dec 31, 2023 | -1.3% | −8.8 |
| Q3 FY2023 | Sep 30, 2023 | 7.4% | +5.9 |
| Q2 FY2023 | Jun 30, 2023 | 8.3% | −1.5 |
| Q1 FY2023 | Mar 31, 2023 | -3.7% | −3.6 |
| Q4 FY2022 | Dec 31, 2022 | 7.5% | −7.9 |
| Q3 FY2022 | Sep 30, 2022 | 1.5% | −12.8 |
| Q2 FY2022 | Jun 30, 2022 | 9.8% | −9.3 |
| Q1 FY2022 | Mar 31, 2022 | -0.1% | −12.4 |
| Q4 FY2021 | Dec 31, 2021 | 15.4% | −4.8 |
| Q3 FY2021 | Sep 30, 2021 | 14.3% | −8.3 |
| Q2 FY2021 | Jun 30, 2021 | 19.1% | +22.4 |
| Q1 FY2021 | Mar 31, 2021 | 12.3% | +36.7 |
| Q4 FY2020 | Dec 31, 2020 | 20.2% | +23.1 |
| Q3 FY2020 | Sep 30, 2020 | 22.6% | +35.5 |
| Q2 FY2020 | Jun 30, 2020 | -3.3% | +8.0 |
| Q1 FY2020 | Mar 31, 2020 | -24.4% | −3.2 |
| Q4 FY2019 | Dec 31, 2019 | -2.9% | +4.2 |
| Q3 FY2019 | Sep 30, 2019 | -12.9% | +7.0 |
| Q2 FY2019 | Jun 30, 2019 | -11.3% | +27.8 |
| Q1 FY2019 | Mar 31, 2019 | -21.2% | +35.0 |
| Q4 FY2018 | Dec 31, 2018 | -7.0% | −2.5 |
| Q3 FY2018 | Sep 30, 2018 | -19.8% | −14.8 |
| Q2 FY2018 | Jun 30, 2018 | -39.1% | −43.7 |
| Q1 FY2018 | Mar 31, 2018 | -56.2% | −48.8 |
| Q4 FY2017 | Dec 31, 2017 | -4.5% | −3.6 |
| Q3 FY2017 | Sep 30, 2017 | -5.1% | – |
| Q2 FY2017 | Jun 30, 2017 | 4.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -7.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -0.9% | – |
See a number that looks wrong?